Detlev Biniszkiewicz is Director of iTeos Therapeutics, Inc.. Currently has a direct ownership of 0 shares of ITOS, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2022, when has been sold 3,500 shares (Common Stock) at a price of $51.9 per share, resulting in proceeds of $181,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Detlev Biniszkiewicz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2022
SELL
Open market or private sale
$181,650 $51.9 p/Share
3,500 Reduced 100.0%
0 Common Stock
Jan 03 2022
BUY
Exercise of conversion of derivative security
$66,500 $19.0 p/Share
3,500 Added 50.0%
3,500 Common Stock
DB

Detlev Biniszkiewicz

Director
Watertown, MA

Track Institutional and Insider Activities on ITOS

Follow iTeos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITOS shares.

Notify only if

Insider Trading

Get notified when an I Teos Therapeutics, Inc. insider buys or sells ITOS shares.

Notify only if

News

Receive news related to iTeos Therapeutics, Inc.

Track Activities on ITOS